Four key developments in U.S. abortion access four years after Dobbs
Select a version of the text written from a presumed ideological perspective. This is not the original text, but a hypothetical version — how someone with that viewpoint might have phrased it. Tapping the current version again will return to the original or select cleaned version.
Since the Supreme Court overturned Roe v. Wade in 2022, abortion rates have risen, telemedicine and shield laws have expanded access, legal battles over medication continue, and public discourse around privacy and stigma is shifting.
Four years after the Supreme Court’s Dobbs decision ended the constitutional right to abortion, the United States faces a complex landscape of state laws, telemedicine services and ongoing litigation. While more than a dozen states have enacted bans, the total number of abortions nationwide has increased each year, driven in part by reduced barriers in states that protect the procedure and by “shield laws” that allow clinicians to provide medication abortions to out-of-state patients via telehealth and mail delivery.
Legal challenges are intensifying. Some Republican-led states are pursuing measures such as charging women who obtain abortions with homicide, allowing private lawsuits against out-of-state prescribers, and classifying abortion pills as controlled substances. Louisiana has sued the Food and Drug Administration over telemedicine access to mifepristone, a case that could reach the Supreme Court and affect nationwide availability of the medication.
Abortion-rights advocates argue that medication abortions are becoming increasingly resilient. A study by University of California, San Francisco researchers examined the feasibility of over-the-counter sales of abortion pills, and a Planned Parenthood affiliate began offering kits for future personal use. Telemedicine providers are also preparing contingency plans to continue mailing misoprostol if mifepristone access is restricted. Elisa Wells of the Plan C project told NPR that medication abortions are “safe, effective and pretty much unstoppable.”
The post-Dobbs era has also altered how privacy and stigma are experienced. Online ordering and home delivery of abortion pills allow patients to avoid public protests at clinics, while social media campaigns encourage individuals to share their experiences openly. Personal stories, such as those of Samantha Casiano and Kate Cox, have highlighted the challenges faced by patients in restrictive states and have contributed to broader public awareness.
Overall, the United States continues to navigate a fragmented regulatory environment, with technology, litigation and public advocacy shaping the future of abortion access.